Table 3.
Association of RR-MTB with Sociodemographic and Clinical Factors of Patients
| Variables | RR Status | P-value | |||
|---|---|---|---|---|---|
| Category | Positive, n (%) | Indeterminate, n (%) | Negative, n (%) | ||
| Total MTB cases | 169 (9.8) | 20 (1.2) | 1525 (89) | ||
| Gender | Female | 67 (10.3) | 7 (1.1) | 576 (88.6) | 0.81 |
| Male | 102 (9.6) | 13 (1.2) | 949 (89.2) | ||
| Age in years | ≤5 | 1 (20) | – | 4 (80%) | <0.001 |
| 6–20 | 27 (10.2) | 5 (1.9) | 232 (87.9) | ||
| 21–40 | 109 (10.5) | 8 (0.8) | 920 (88.7) | ||
| 41–60 | 25 (12.4) | 2 (0.1) | 174 (86.5) | ||
| 61–80 | 4 (2.2) | 4 (2.2) | 166 (95.4) | ||
| >80 | 3 (9.1) | 1 (3) | 29 (87.9) | ||
| HIV status | Positive | 16 (12.5) | 5 (3.9) | 107 (83.6) | 0.032 |
| Negative | 10 (7.2) | 12 (8.7) | 116 (84.1) | ||
| Unknown | 133 (9.2) | 3 (0.2) | 1312 (90.6) | ||
| TB category | New cases | 118 (8.3) | 6 (0.4) | 1291 (91.3) | 0.025 |
| Relapse | 38 (15.76) | 9 (3.7) | 194 (80.5) | ||
| Treatment after failure | 10 (22.2) | 3 (6.7) | 32 (71.1) | ||
| Treatment after lost to follow-up | 3 (23.1) | 2 (15.4%) | 8 (61.5) | ||